SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " harm " 2,192 found 🔀 AI-powered Shuffle
Mental health and ADHD diagnosis can cause harm, says official review
Government-commissioned report calls for more opportunities to work and socialise for young people and rejects claims of ‘snowflake’ generation
MLK Health Center and Pharmacy hosts 14th annual Mammograms and Manicures event
The MLK Health Center hosted its annual Mammograms and Manicures event, offering women complimentary manicures and breast exams.
MLK Health Center and Pharmacy hosts 14th annual Mammograms and Manicures event
The MLK Health Center and Pharmacy hosted its 14th annual Mammograms and Manicures event Thursday, offering breast cancer screenings to help uninsured and underinsured patients access preventive care.
AI pricing lawsuit against McDonald's raises new antitrust questions
A federal antitrust lawsuit against McDonald's this week claims the fast-food giant is using AI-powered tools to fix menu prices, marking the latest case to allege companies are relying on new technologies to collude and harm consumers.
Louisiana Activists Draw Links Between Petrochemical, Climate Harm to Maternal Health
Louisiana feminist activists came together on October 2 at the annual Black Birth Matters conference to demand that policy makers consider how toxic air pollution and other environmental damage negatively impact reproductive health.
Life Is Asymmetric. The Scientists Who Figured Out Why Won the 2026 Nobel Prize in Chemistry
Henri Kagan and Kensō Soai designed chemical reactions producing only one of the two mirror-image forms of a molecule—an important finding for the synthesis of pharmaceuticals and other biological substances.
‘Political chameleon’: How Mark Zuckerberg charmed Trump and got his way on AI
It was a triumphant moment for Mark Zuckerberg. He sat at the center of last month’s White House AI meeting, with the CEOs of some of the biggest tech companies in the world signing onto a document he crafted for how to “self-police” and attempt to manage serious AI safety risks. After the meeting, Zuckerberg called it “historic.”
GLP-1s: the science behind today’s weight-loss drugs
The medicines reshaping obesity treatment grew out of research into how the body handles a meal. Long before weekly weight-loss injections became familiar, scientists were studying signals that travel from the intestine to the pancreas, helping it release insulin when nutrients arrive.
UNM College of Pharmacy to Offer Free Health Services
Community Outreach Day brings flu vaccines, health screenings and education to multiple Albuquerque locations on October 16
Japan, U.S. business leaders urge governments to boost AI cooperation
Japanese and U.S. business leaders on Wednesday called on their governments to step up cooperation on artificial intelligence, ranging from measures to support corporate procurement of necessary power sources to harmonizing governance of the rapidly growing technology.
After vast sewage spill, officials say testing shows Potomac is back to health
Testing “found no current signs of harm” from the millions of gallons of raw sewage that flowed into the river in January, according to D.C. Water.
Trump is betting the third time will be the charm to hold ‘em in Texas
Earth Science Tech (ETST) Building on Synergies Between Healthcare Related Subsidiaries to Generate Dependable and Growing Revenue
Austin, Texas, October 7th, 2026, FinanceWireEarth Science Tech (OTCQB: ETST), a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces, operates Avenvi LLC, a real estate and asset…
ULM grad named America's top independent pharmacist
Louisiana Governor Jeff Landry praised America's top independent pharmacist who graduated from ULM
From 1800s to modern pharma: a Nobel-winning chemistry quest
Wednesday's Nobel chemistry prize crowned a series of advances that started in the 19th century and led to breakthroughs for modern pharmaceutical manufacturing.In 2001, US scientists William Knowles ...
Inside Microsoft's plan to boost Xbox, Battle.net on PC — "Right now, it is simply very hard to work with Xbox," said Asha Sharma, with plans to fix it
Microsoft has long identified Battle.net as a key part of its Activision-Blizzard acquisition, and at yesterday's Town Hall with Xbox CEO Asha Sharma, we got more hints about the future.
Walgreens owner sells Boots for $8.9 billion
The sale marks Sycamore Partners' first major divestiture since buying the Deerfield-based retail pharmacy chain and breaking it up into standalone businesses.
CVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
Eligible patients can receive MMR vaccinations at more than 530 CVS Pharmacy® locations across New York and at MinuteClinic® locations WOONSOCKET, R.I., Oct....
Jonathan Rivnay receives Blavatnik Award for Young Scientists
Soft bioelectronics and living pharmacy devices recognized with prestigious award and $250,000 prize
AMO Pharma in Collaboration with Population Health Research Institute (PHRI) and Venca Research Inc. Announces FDA Advice on Potential Phase 3 Development Path for AMO-02 in Treatment of Arrhythmogenic Cardiomyopathy (ACM)
/PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with...
Asha Sharma reportedly informs staff that Xbox has "started to return to growth" during internal town hall
"We're making the right decisions to reinvest in the business," says Sharma as Xbox continues to undergo major restructuring
Rising Stars: How VML Health’s Molly Kanofsky turns ‘an idea on a page’ into real-world impact
Molly Kanofsky had it all planned out. | VML Health's Molly Kanofsky ended up in the pharma marketing world after an unexpected career detour, where she's now able to merge her passion for healthcare with her creative side.
Tom Cruise digs into uncharted territory in ‘Digger’
Don’t look now, but Tom Cruise’s latest movie, Alejandro G. Iñárritu’s Digger, is not your typical Tom Cruise film. The charming, boyish-looking star of Mission: Impossible fame is shedding his familiar action-superstar image. Wearing a fat suit, cowboy boots and disheveled hair, and at one point carrying a dying cat, Cruise portrays Digger Rockwell, an egocentric, fast-talking octogenarian oil billionaire whose irresponsible drilling…
Kyle Austin touts business experience in bid as Libertarian for U.S. Senate
Kyle Austin is the Libertarian candidate in Montana’s U.S. Senate race. The 43-year-old pharmacy owner and farmer says he’s had a desire to serve in a federal office since he was a teenager.
Kyle Austin touts business experience in bid as Libertarian for U.S. Senate
Kyle Austin is the Libertarian candidate in Montana’s U.S. Senate race. The 43-year-old pharmacy owner and farmer says he’s had a desire to serve in a federal office since he was a teenager.
UNC Health's Cary campus to offer a variety of care including cancer, heart and vascular and OB-GYN
The medical facility will offer cancer care, heart and vascular care, orthopedics, OB-GYN services, imaging, laboratory services and a pharmacy.
Xbox CEO Asha Sharma speaks at internal town hall — Discussing Xbox Series X|S as 'core,' Helix as a family of devices, boosting Game Pass, and more
EXCLUSIVE: In a recent town hall with Microsoft gaming staffers, Xbox CEO Asha Sharma described how Xbox was in "free fall" declines before this year's big restructure.
IPM Food Pantry adds a new harm reduction vending machine
The Ohio Department of Health lists nearly 100 Naloxone vending machines all across the state
Charm Security Appoints Dr. Elizabeth Huppert as Behavioral Science Director
Former JPMorgan Chase Vice President and Behavioral Scientist joins to advance behavioral science in agentic AI for fraud, scams, and cybercrime.NEW YORK, NY / ACCESS Newswire / October 6, 2026 / Security today announced the appointment of Dr.
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Participants in the panel discussion include Dr. Christos Tzivinikos, and Pravin Chaturvedi, PhD, Napo's and Jaguar's Chief Scientific Officer and Chair of the Scientific Advisory Board.
'Captaincy ends': Harmanpreet Kaur’s top five achievements as India captain
Harmanpreet Kaur has stepped down as India’s all-format captain after a landmark leadership stint. Her tenure featured India’s maiden ODI World Cup title in 2025, a record number of T20I wins as captain, four Asia Cup triumphs, the milestone of captaining 150 T20Is and a historic Test victory at Lord’s. She now returns to playing cricket.
India's Harmanpreet steps down as captain
India batter Harmanpreet Kaur leaves her role as national team captain across all three formats of international cricket.
Climate Science Under Political Attack Reaches US Supreme Court
In 2018, local officials in Colorado sued oil companies in state court, charging that pollution from fossil fuels contributed to global warming and harmed
Introducing: The Seiko Panda Watch That Stole The Show In 2024 Is Finally Here
One of the standout creations from Seiko's 2024 power design project—an irresistibly charming chronograph designed to look like an actual panda—has officially entered production.
Pennsylvania passes 1,000 measles cases as PA health secretary says CDC is minimizing five measles associated deaths
Pennsylvania Health Secretary Dr. Debra Bogen visited a Pittsburgh pharmacy to raise awareness about respiratory illnesses, including COVID-19 and the flu, while addressing the state's rising measles cases.
Swedish regulator temporarily revokes Charm Entertainment’s casino license
The Swedish Gambling Authority (Spelinspektionen) has issued a temporary revocation of Charm Entertainment AB’s license to operate commercial land-based casino
Health Influencer Brags About Drinking From a Radioactive Jug for 250 Days Straight
Radium water products were banned in the U.S. roughly a century ago for causing cancer and other harms.
‘Please get vaccinated,’ state health secretary urges as new COVID-19 vaccines roll out
In the midst of a historic measles outbreak, state and local health officials crammed into the family-owned Hilltop Pharmacy in Allentown on Monday to...
Derrick Harmon placed on Injured Reserve
Steelers DT Derrick Harmon placed on IR after Week 4 injury
Did New Science Board Just Shift BioCryst's (BCRX) Investment Narrative?
BioCryst Pharmaceuticals recently formed a seven-member Scientific Advisory Board made up of experienced rare disease and drug development leaders to guide its research, clinical plans and regulatory approach. The depth of this board, spanning big pharma R&D, AI driven drug discovery and rare disease commercialization, directly targets BioCryst’s execution risk as it builds a broader pipeline beyond its current portfolio. We will now examine how BioCryst Pharmaceuticals’ investment narrative...
Steelers will put DL Derrick Harmon on injured reserve
Blue Turf Thinkers: Biomedical Research Institute investigates harmful diseases
At each Boise State home football game, the “Blue Turf Thinkers” series honors outstanding groups...
‘NCIS’ Star Mark Harmon Reveals Why He and His Wife Pam Dawber Keep a Low Profile
They've been married since the late ’80s!
More than a prescription: Removing barriers so patients can get back to living
See how integrated specialty pharmacy support helped one patient overcome treatment barriers and get back to the moments that matter most.
Who will rural voters blame for harmful healthcare changes, policies this election?
Inflation and affordability, immigration and international conflicts may be dominating much of the news—and voters' attention—but healthcare, as always, still matters at the ballot box—perhaps even more so for rural voters.
GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business
Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and distribute PET imaging drugs.
Bill's Prescription Center remains family business in Brandon
Bill's Prescription Center continues operating as a multi-generational family pharmacy in Brandon, maintaining its commitment to personalized care despite rapid regional growth.
Swedish regulator temporarily revokes Charm Entertainment AB’s casino licence following investigation
Spelinspektionen issued an interim revocation of Charm Entertainment AB’s licence to operate commercial land-based casino gaming.
Yale School of Medicine On the Science of Childhood Anxiety, Say, Anxiety Disorders Are the Most Common Mental Health Challenges In Youth
Credit: Matt Bradbury October 5, 2026 - By Isabella Backman - Anxiety disorders are the most common mental health challenges in youth. Left untreated, they can disrupt the lives of both children and their families. The good news is that with intervention, most children will overcome these conditions. Across Yale School of Medicine, scientists are working to understand anxiety at every level, from common anxious behaviors to molecular biomarkers in the brain. They are using their findings to develop and disseminate new evidence-based treatments for childhood anxiety. Today, the go-to treatment for childhood anxiety disorders is cognitive behavioral therapy (CBT). This is a form of psychotherapy that teaches children skills for confronting anxious thoughts and helps them practice managing situations that cause anxiety. While it is the gold-standard treatment backed by considerable scientific evidence, up to 50% of children will not see sufficient benefit from CBT alone. Wendy Silverman, PhD, Alfred A. Messer Professor in the Child Study Center, co-directs the Anxiety and Mood Disorders Program alongside Eli Lebowitz, PhD, associate professor in the Child Study Center. One of their main interests is learning how to improve outcomes beyond CBT. “We’re developing cutting-edge, research-based knowledge that can reduce the suffering that anxiety causes children and their families,” says Silverman. Changing parent behavior YSM experts are investigating how to improve CBT outcomes for children by involving the parents. Silverman’s research has uncovered two main components of parent intervention that improve childhood anxiety: not enabling children to completely avoid the things that make them anxious and taking steps to enhance their autonomy. Parents may unintentionally reinforce their child’s anxiety by allowing them to avoid what makes them anxious. They also may unintentionally limit the children’s sense of autonomy by being overly intrusive. “One of the things that we take pride in is that we’ve focused on trying to understand what parents need to do, and to test our ideas and see if changing the parents’ behaviors is enhancing the effects of CBT,” Silverman says. “Our findings thus far suggest that they do." As much as CBT can be helpful, it can also be challenging to get one’s child to do the necessary steps for CBT to work. This is one important reason why Lebowitz created a novel intervention program for parents named Supportive Parenting for Anxious Childhood Emotions (SPACE). Existing intervention programs often teach parents to act as therapists for their child, such as training them on how to practice breathing exercises. “It makes sense, but this doesn’t work very well in practice,” says Lebowitz. “And part of the reason, I think, is that it’s not easy to get your kid to do things, especially if they’re not excited about doing it.” SPACE is unique because it focuses entirely on parent involvement and changing parental behavior—children are not involved in the sessions. For example, parents learn how to use supportive messages that convey confidence that their child can tolerate and manage distress. “It might sound like a parent saying to a child, ‘I get that this is really hard for you, but I know that you can handle it,’” Lebowitz says. The program also works with parents to identify the ways in which they are accommodating anxious behaviors. “We’ll pick one thing that parents are doing that is an accommodation and help them make a detailed plan for how they’re going to change that,” Lebowitz explains. Treating Anxiety in Children and Adolescents Much of the existing research on SPACE has focused on parents of children under age 14. Ongoing studies are now exploring its use with parents of older teens. “Both anxiety and accommodation can interfere with normative developmental shifts during the teen years, including increased autonomy and individuation from parents,” says Rebecca Etkin, PhD, associate research scientist in the Child Study Center. “In this sense, SPACE may be particularly well-suited for anxious teens and their parents. We want to see whether it is effective during this distinct developmental window.” Unfortunately, many families in need of CBT face barriers, including limited availability of services and geographic constraints. One way to improve access is digital interventions. Silverman and her team are developing an evidence-based digitized intervention program for parents that they can access directly from their computer or smart phone. “The work we’re doing will be one of the very few parent interventions that is digitized and importantly tested for effectiveness,” she says. Creating interventions for anxiety-related challenges Silverman and Lebowitz recently received a generous gift to develop and test other interventions that help parents reduce other child anxiety-related behavioral and emotional difficulties, such as restrictive eating and unexplained somatic symptoms. One of these projects in particular focuses on understanding the risks of social media and its potential benefits, including offering a sense of connection. “A lot of research has focused on the idea that social media is harmful and the less of it the better,” says Lebowitz. “But we actually see is that this is not quite right—there are negatives, but there are also positives. So, we’re trying to get a little bit more nuanced of a picture.” The team is working with teens with social anxiety and their parents over an extended period to better understand their social media habits and how their anxiety levels affect engagement with different platforms. The teens will answer questions sent to an app on their phones about mood and social media usage in an effort to capture emotional responses as they unfold. “We hope to develop interventions that can help make the best of social media while protecting against the more problematic effects,” Lebowitz says. The brain’s role in anxiety Researchers are also testing therapies to address anxiety at the neurological and molecular levels. In collaboration with Dylan Gee, PhD, professor of psychology in Yale's Faculty of Arts and Sciences, and Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience at Yale School of Medicine, Lebowitz and Silverman are using brain imaging to identify changes in a child’s brain before and after parents enroll in SPACE. In one study, children viewed anxiety-inducing images while undergoing magnetic resonance imaging (MRI); the researchers conducted scans with and without the children’s parents nearby. Before SPACE, children’s brains were better able to activate the regulatory circuitry needed to turn off an anxious response when their parents were nearby. But after SPACE, children could activate this circuitry even without the parent around. “As parents work on gradually reducing some of their accommodations, you can see a child get better at regulating their own fear system in the brain,” Lebowitz says. “It’s remarkable.” Research into the molecular underpinnings of anxiety can also inform new childhood anxiety treatments. In a recent study, Lebowitz, Silverman, and Flora Vaccarino, MD, Harris Professor in the Child Study Center, discovered that a protein known as fibroblast growth factor 2 (FGF2) could be protective from the toxic effects of stress. FGF2 levels in children and their parents were linked to the children’s risk of developing anxiety and depression, the study showed. The findings could help explain why some children who are exposed to early life trauma such as poverty or abuse are more prone to developing mental health disorders. And FGF2 could be a target for treatment. “This is very novel because it starts to give a clue to what is the molecular chain that connects those lived experiences to the actual psychological outcomes,” Lebowitz says. New ways to study and treat childhood anxiety Michael Crowley, PhD, associate professor in the Child Study Center, collaborates with Silverman and Lebowitz to study the role that attention plays in development and maintenance of childhood anxiety. There is a large body of research that shows that anxious children, like anxious adults, are prone to focus on threatening stimuli such as angry faces compared with neutral faces. This has led to innovative interventions that involve attention retraining. The idea is that if experts train children to look away from threatening stimuli, it may reduce their anxiety—especially children with social anxiety who are most prone to attend to threats. The researchers have just completed a clinical trial for attention retraining with 10- to 14-year-olds with social anxiety disorders and are currently analyzing the findings. Besides this innovative attention retraining research, as Crowly notes, “I like to design tasks that are engaging to kids,” Crowley says. “My goal is to assess something without the kids knowing what we are assessing.” With this goal in mind, Crowley has created a virtual game, named Boom, to study threat processing in children with anxiety disorders. The game is similar to that of hot potato—the child and three digital players take turns virtually passing a ball to each other’s gloves. At some point, the ball turns into a bomb, and as the bomb lands in each player’s glove, the outline of the glove turns yellow. The goal is to avoid having the bomb go off in your glove. What isn’t obvious is that the game is designed to measure different types of threatening stimuli, both ambiguous and direct. In the game, the direct threat occurs as the bomb is traveling towards your glove. The ambiguous threat is the yellow outlined glove as it is unknown where the bomb will travel next. While children play the game, Crowley’s team measures their brain activity using electroencephalography (EEG). The researchers have discovered that in kids with anxiety, the brain reacts more strongly to ambiguous threats than it does in their peers, but less strongly to direct threats. They believe that the initial abnormally large brain response to not knowing where the bomb is going impairs the brain's ability to properly respond when the threat is actually traveling the child’s way. “The brains of children with anxiety are unable to differentiate between threats you need to do something about and those that are not your problem.” Michael Crowley, PhD, develops innovative games for studying anxiety in children and adolescents.Credit: Matt Bradbury Based on these insights, Crowley hopes to study whether interventions like attention training could restore appropriate threat processing. Crowley’s team is also working on a test called the Balloon Risk Avoidance Task, which evaluates risk-taking and avoidance behaviors. It features a digital balloon that is full of air and about to burst. Kids have six seconds to let air out of the balloon. The more air they let out, the less risk they face that the balloon will pop. But at the same time, the balloon becomes less valuable as it deflates. “The more air you keep in the balloon, the more points you get,” Crowley explains. So far, the researchers have found that when the balloons pop unexpectedly, teens with social anxiety show distinct brain responses. Studying these responses can help psychologists understand the underlying pathways driving the various manifestations of anxiety. The genetics of anxiety When Thomas Fernandez, MD, associate professor in the Child Study Center and of psychiatry, was still in training, there was a lot of excitement about understanding the genetics associated with autism spectrum disorder. Since then, scientists have identified around 250 genes associated with autism. The genetic contribution to anxiety disorders, on the other hand, has historically received less attention. Anxiety is less heritable than autism, but the genetic contribution for anxiety disorders that emerge in childhood may be higher than for anxiety disorders overall. While scientists estimate the heritability of anxiety disorders in general to be around 30% to 50%, some studies suggest higher heritability for certain childhood-onset anxiety presentations. “I saw firsthand how researchers in the field went about finding vulnerability genes for autism,” Fernandez says. “So, we’re using a very similar playbook for childhood anxiety.” “I saw firsthand how researchers in the field went about finding vulnerability genes for autism. So, we’re using a very similar playbook for childhood anxiety.” Thomas Fernandez, MD Associate Professor In the Child Study Center and in Psychiatry Now, Fernandez and Emily Olfson, MD, PhD, assistant professor in the Child Study Center, are studying children and their parents to identify genetic changes that are present in the child but not the parents, known as “de novo mutations.” “All of us have some de novo mutations—maybe about 50 to 100 sprinkled throughout the genome,” Olfson says. “But when they occur within the coding regions of genes, they can be really disruptive.” Previous research shows that people with autism have higher rates of damaging de novo mutations than the general population. In 2022, Olfson, Lebowitz, Silverman, and Fernandez published a study on 68 children and their families that found that children with anxiety had similarly high levels of these mutations. Studying de novo mutations can help point the researchers to where they should be looking for genes associated with anxiety. “The end game is using the genes to steer us toward the right part of biology that we can then target to come up with better treatments,” Fernandez says. Building on those findings, the team is now studying more families to better understand how these de novo mutations, along with other genetic and environmental factors, shape pediatric anxiety disorders. They recently received a National Institutes of Health grant to enroll 750 new families over the next five years. Olfson is the principal investigator, with co-investigators Lebowitz, Fernandez, Silverman, and Shuangge Steven Ma, PhD, department chair and professor of biostatistics at Yale School of Public Health. Neurodevelopment, Risk Genes, and Mental Health Conditions - The Olfson Lab Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, is interested in how different anxiety disorders differ genomically. “We are studying social phobia, panic disorder, and generalized anxiety disorder, working to understand why people differ in their risk to these specific anxiety disorders and evaluating various risk factors,” he says. Gelernter was recently involved in one of the largest studies to date of the genomics underlying anxiety disorder. The study included around 122,000 people with anxiety disorders and around 730,000 without. It found that some genetic differences associated with anxiety were linked to signaling that helps reduce overactivity in the nervous system. Many anxiety medications available today work by targeting this process. “It’s nice when the biology that you get out of a large genome-wide study ratifies things that we already know because that can help increase confidence in further findings from the study,” Gelernter says. Uncovering the neurobiology of psychiatric disorders John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and chair of the Department of Psychiatry, is interested in the neurobiology of psychiatric disorders, including post-traumatic stress disorder (PTSD), of which anxiety is a major symptom. In the late 1980s, Krystal’s team discovered that the drug yohimbine activated symptoms in patients with PTSD. “This was the first time we could link a specific biological mechanism to the symptoms of PTSD,” Krystal says. At the time, he adds, this finding was highly controversial. “A lot of people felt that PTSD was a purely psychological syndrome that didn’t have an underlying biology.” Since then, Krystal has dived deep into understanding the neurobiology of PTSD to learn how to better treat it. His team is evaluating the use of ketamine and psychedelics. These would be among the first treatments to be developed specifically for PTSD. They may also be applicable for other disorders including anxiety disorders, Krystal adds. An important gap in PTSD treatment is the absence of biological tests that inform how to best help patients manage their PTSD symptoms. A doctor doesn’t diagnose cancer based on how they feel. Rather, they use tests of the biology of the cancer to determine the best course of treatment. “And we can’t do that in any psychiatric disorder other than Alzheimer’s disease,” Krystal says. “But now we are building a foundation for this approach to the treatment of anxiety disorders for the first time.” Source: Yale School of Medicine
UT San Antonio Health Science Center study finds elevated levels of toxicants in teeth of children with autism
Suggests children are ‘chronically and repeatedly exposed’ to dozens of potentially harmful chemicals Contact for media: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, Oct. 5, 2026 – A pilot study by The University of Texas at San Antonio Health Science Center found elevated levels of toxicants in the primary teeth […]
UT San Antonio Health Science Center study finds elevated levels of toxicants in teeth of children with autism
Suggests children are ‘chronically and repeatedly exposed’ to dozens of potentially harmful chemicals Contact for media: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, Oct. 5, 2026 – A pilot study by The University of Texas at San Antonio Health Science Center found elevated levels of toxicants in the primary teeth […]
Republicans and Democrats find a unifying target: Pharmacy benefit managers
Republicans and Democrats, both patients and politicians, seem united in their disdain for the healthcare companies known as pharmacy benefit managers. Tennessee and Arkansas are regulating them now.
Doctors Should Keep an Eye on Your Mix of Medication. If They Don’t, You Should.
There’s a term for reducing unnecessary or harmful drugs: “deprescribing.” Especially as patients age, experts say, it’s important to regularly review the medications they’re taking.
Hospital and pharmaceutical prices are smothering America’s businesses
Workers and employers are drowning in their health insurance premiums. The reason for that deluge: the health care industry’s high and inscrutable prices.
Averly Health launches to transform cardiometabolic care in the UK
Averly Health, a joint venture between Reset Health and Pharmacy2U creates the first and only fully integrated national cardiometabolic care provider....
Averly Health launches to transform cardiometabolic care in the UK
Joint venture between Reset Health and Pharmacy2U creates the first and only fully integrated national cardiometabolic care provider.Averly Health will set a new standard for access and outcomes to transform the population’s health across chronic diseases like obesity, type 2 diabetes and cardiovascular disease.Averly Health combines Reset Health’s specialist cardiometabolic clinical expertise with Pharmacy2U's market-leading digital prescribing and pharmacy infrastructure to deliver a seamless
You should avoid using a screen protector on your MacBook
Screen protectors can do more harm than good.
The Watch: Pesticide Contamination Threatens Drinking Water Sources
Atrazine is detected at harmful levels in more a quarter of rivers and stream miles … Few volunteer firefighters get health screenings … and more.
From nearsightedness to self-harm: Meta-review looks at how digital media impacts young people’s health
The authors of an expansive new series in ‘The Lancet’ argue that gaps in our understanding about digital harms shouldn’t delay urgent policy action.
Global action urged over digital media’s harm to young people’s mental health
In an effort to build a ‘healthier digital world’ for young people, experts are calling on tech firms to release data showing how platform features affect user wellbeing
Business People: Dana McNabb promoted to CEO at General Mills
FOOD General Mills, Golden Valley, announced the election of Chief Operating Officer Dana McNabb to succeed Jeff Harmening as chief executive officer, effective Jan. 1. Harmening will become executive chair of the board of directors.…
How Long-Term Climate Change Harms Human Health - Global Health Otherwise
How Long-Term Climate Change Harms Human Health - Global Health Otherwise / Ana Maria de Roda Husman, cancer, Dieneke Bijkerk-Schram, Fábio Serafim, Global
Guest Commentary: Affordability without access isn’t sound health policy
Byron Donalds’ record of politicizing his health policy is harmful, writes a former healthcare CEO.
UISD Gateway partnership expands employee health care access
UISD and Gateway Community Health Center signed an agreement expanding affordable health care access for employees through clinics, mobile units, pharmacy and preventive services.
Emma Lees: Eight Years of Science, Patients and Progress
Emma Lees: Eight Years of Science, Patients and Progress / Biopharmaceutical Research, BMS, Bristol Myers Squibb, Cambridge Crossing, Cambridge Research,
What to remember before reading 'ACOTAR' book 6 by Sarah J. Maas
Sarah J. Maas' new book, "A Court of Splintered Harmony," will continue storylines from "A Court of Thorns and Roses" and "Crescent City."
Energy drinks and overcaffeinated kids: What to know about the health risks
Doctors nationwide have warned for years that energy drinks contain high levels of caffeine that can seriously harm children.
Doctors warn about the risks energy drinks pose to kids. What families need to know
Doctors nationwide have warned for years that energy drinks contain high levels of caffeine that can seriously harm children
Your gut may be making a molecule that raises Alzheimer’s risk
Scientists have linked a gut bacterial compound called ImP to greater Alzheimer’s risk, harmful brain protein buildup, and faster cognitive decline. The finding raises the possibility that reducing ImP in the blood could one day help slow or prevent dementia.
Meta wants you to build your own Muse gadget
Meta wants Muse in your TV and your toaster, so it's giving the code away for free.
Why Is CVS Health (CVS) Reworking Primary Care Around Value Based Care?
CVS Health (NYSE:CVS) is expanding its primary care approach by integrating value-based care across its health system. The company intends to connect health plans, provider groups, clinics, and pharmacies under a single patient-centered care model. Management is targeting shared accountability for outcomes that include social determinants of health alongside traditional clinical metrics. This push to embed value-based care across CVS Health's operations reshapes how the group manages care,...
Weiser joins lawsuit challenging new fuel economy standards
“The federal government’s backsliding on standards for the next five years requires less fuel economy than what the U.S. fleet of new cars and trucks achieved in 2021. Rolling back fuel efficiency standards will cost Coloradans even more at the gas pump, harm public health, and undermine our nation’s position in the EV market. These clean car rules are part of our clean energy future and that’s why we are challenging this illegal action,” said Attorney General Weiser.
Scoop: Renovus preps two pharma services companies for sale
The processes would launch in a robust deal market.
Merck business unit opens R&D facility in Sheboygan Falls
EMD Electronics, the North America electronics business unit of Germany-based global health care and biopharmaceutical company Merck KGaA, today announced
Nursing home oversight lags, putting residents at risk
A recent KFF analysis of federal nursing home oversight found an association between short staffing and serious harm to residents.
Research uncovers how bacteria fight viruses, opening the door to better virus-based antibiotics
Bacteriophages are viruses that can attack harmful bacteria, whose "last resort" immune response kills the infected bacterium before the virus can spread to others.
Don't let the adorable AI agents fool you
Just because they look harmless doesn't mean you should be irresponsible with your data.
Anthropic tells IPO investors US government actions could hit its business
Anthropic’s IPO prospectus warns that US government actions could harm its commercial customer and partner relationships, Reuters reports.
Seaweed strandings cause a stink – here’s why they harm your health
When free-floating patches of seaweed are pushed together by currents and winds, seaweed strandings can inundate the coastline with often devastating consequences.
Harmison signs first professional Durham deal
Charlie Harmison, son of 2005 Ashes winner Steve, signs a two-year deal with Durham.
Fear, Mistrust, and Harm in Police-Involved Mental Health Crises
This week, Mad in America explores three new studies around mental health crisis calls involving police. The first study finds that patients and service Studies highlight patient and community concerns about police responses alongside gaps in training, communication, and crisis alternatives
Patient Dies by Suicide After ‘Insurance Issue’ Delayed Medicine for Lung Disease Flare-Ups
Hours after experiencing a flare-up related to chronic obstructive pulmonary disease, Kenney Blewett of Kyle, Texas, died by suicide in June. A medication his doctor prescribed days earlier to ease his breathing problems hadn’t been filled due to an “insurance issue,” his pharmacy explained via email.
Steelers' Derrick Harmon Carted Off With Foot Injury Against Browns
Pittsburgh Steelers defensive tackle Derrick Harmon was carted off with a foot injury against the Cleveland Browns.
SpyGlass Pharma Acquires Advanced Vision Science, Securing Commercial IOL Supply, Accelerating Lens Portfolio Expansion
IRVINE, Calif.—SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company focused on transforming treatment paradigms for patients with chronic eye conditions, has announced the acquisition of all the outstanding shares of common stock of Advanced Vision Science, Inc. (AVS), an ophthalmic medical device company and manufacturer of intraocular lenses (IOLs) and lens materials, for approximately $13 million in cash. This acquisition secures scalable commercial IOL supply and accelerates lens portfolio expansion capability for SpyGlass Pharma, the announcement noted.
Military Leaders Will Examine Ways to Limit Civilian Deaths in War
U.S. Central Command will hold a daylong conference at its Tampa headquarters after seven months of war in Iran.
Wilson Sonsini Advises SpyGlass Pharma on Acquisition of Advanced Vision Science
On October 1, 2026, SpyGlass Pharma, a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions, announced the acquisition…
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
The portfolio comprises more than 15 proprietary brands and product lines and 10 branded generics across five product categories, sold in more than 40 countries through pharmacies, hospitals, retail chains and e-commerce. It is manufactured at GMP-certified facilities in Europe and the United States and supported by the Company's services in contract manufacturing, pharmaceutical distribution, telehealth and research and development.
Midtown Costco set to close, reopen as business center
Costco has committed to keeping the Midtown pharmacy open during the conversion.
Across the Globe, People Increasingly Say Social Media Is Harming Democracy
Most think social media leads to manipulation and division, but they also say it informs people and gives them a voice in politics.
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032
Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.
Xtalks Announces its Life Science Webinar Calendar for October 2026
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Xtalks Announces its Life Science Webinar Calendar for October 2026
/PRNewswire/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries....
Vietnam Pandora Jewelry
A model holds up a bracelet charm with trinkets of Vietnamese map and flags at the Pandora factory in Ho Chi Minh city, Vietnam, Wednesday, Sept.30, 2026. (AP Photo/Hau Dinh)
September Monthly Review: Health MCP Guy?
For all the time I spend talking about APIs and data exchange, this newsletter has had embarrassingly little interoperability of its own. It’s old-school SaaS, baby - UI or bust. Not all of that is my fault! Substack, for all its popularity, is (as mentioned before) really frustrating as my system of record. The primary user it optimizes towards is the reader, whose attention feeds the app, the Notes feed, and the recommendation network that Substack is actually selling. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe They’re falling into the same trap that Medium once sprinted into, albeit at a much more glacial speed. Younger generations may not remember (or never knew) it, but Medium once lured publications like The Ringer and Signal v. Noise onto its platform, only to lose them as it rebuilt itself around a paywall and an algorithmic feed. Substack’s original pitch circa 2020 was the antidote (you own your list), but every new feed feature chips away at it. I get it: writers are generic supply in the eyes of the Substack product team. Generic supply follows demand, so the consistent pressure on the PMs is to generate demand, which leads to every product cycle going toward discovery (Notes, recommendations, the app, live video). The end result lackluster author tools (laggy and broken analytics are truly crippling) all despite the premium price point. The archive is where it crosses from authorial gripes to actual reader impact, though. Across Substack and LinkedIn, I’ve published 1,218 posts and nearly 900,000 words since 2018. Substack’s native search can see only the 464 posts that live on Substack, and even there it’s woefully inadequate at surfacing relevant content (even for the guy who wrote it)! Readers have the same problem, writ large. Ask the Archive Fixing search (for both my readers and my own use) turned out to be extremely non-trivial, unfortunately: There’s no public API for readers to access content RSS exists for new content notification, but it only carries the 20 most recent posts and cuts paid ones off at the preview The only Substack MCP is an admin tool for analytics The export exists for authors, but it’s painfully awkward and slow. So I built something to work around that: the Health API Guy MCP. It’s a private MCP server holding the full text of everything I’ve written across Substack and LinkedIn. Add it to Claude or ChatGPT as a connector and you can ask things like: It pairs keyword search (for acronyms and case names, of which we have many) with semantic search. Every post is also labeled by topic, form, and court case, so you can pull a lawsuit’s (or multiple cases’) entire docket across Substack and LinkedIn in one query: Hail, Healthapiguyhydra This is also a bit of me eating my own cooking. I’ve spent the year arguing that headless healthcare is arriving and that developers want primitives over abstractions. Last week in Hail, Benihydra, I watched Salesforce plug its platform into Claude and bet that the records underneath outlive whatever interface sits on top: Salesforce must believe that the Hydra’s immortal head is the records, permissions, and business logic (in that they will survive whatever happens to the interface). It felt a bit hypocritical to keep my own archive behind a Substack search bar. The archive is the body. Substack is one head, and now whatever tool you might use is another. Will the EHRs follow my lead? Probably not imminently, but one can hope! Why Founding Members Only The MCP is available to Founding Member subscribers. A few reasons: It costs money and time to run. Hosting, the database, Clerk usage and AI compute for search and labeling are significant operational costs (that increase with usage). Substack gives me no way to automate access. There’s no API to check whether someone is a paid subscriber, so every user is manual operations for now. It’s a beta. We’ll need to improve things and parts will break. I’d rather they break for a small group of dedicated readers who will tell me about it. The Founding tier deserved a real benefit. Until now it was mostly a generous tip. Now it comes with something. If you’re already a Founding Member, reply to this email with the address you’d like provisioned. If you’re not and want in, upgrade here. Larger teams (such as companies) can get access too: group subscriptions at the Founding tier come with the group discount. The admin for the subscription can reply with the list of addresses to provision. Get 20% off a group subscription Pricing Founding membership is now a flat $200 a year, replacing the old suggested $150 that readers could adjust. Existing Founding Members will have access grandfathered in at their previous rate. Month in Review Articles Published Make Networks Dumb Again (Sep 11): AI is making old analog networks cheaper to use and flooding them with machine traffic in the process. A plea for agent-native rails with the intelligence at the endpoints, and for Washington to drag them to ubiquity. Interoperability, Unbuttoned (Sep 29): Interoperability is a series of workflows in a trenchcoat, and this post finally takes the trenchcoat off. A color-coded map shows which provider workflows went digital, which are fragmented, and which still run on fax. Video Content Antitrust’s System of Record Problem (Sep 3): The FTC’s investigation into Epic prompted a ninety-minute webinar, now posted with chapters and a smoothed transcript. We get into why market definition, missing B2B share data, and the SSNIP test leave antitrust poorly suited to systems of record, plus why information blocking may be doing more than any pending lawsuit. The Information Exchange: Cerner Milking Edition (Sep 18): This was so fucking fun. Ryan Tucker, Ryan Brickner, Brad Thorson, and I try an Around the Horn format, complete with points, penalties, and a mute button. We debate whether Oracle Health is dead, who would actually buy Cerner (IBM enters the chat), p(Doom), and why the front desk still hands you a clipboard. Regulatory Ask Not What Your Network Can Do (Sep 23): CDC’s RFI on public health data intermediaries lists use cases already served, unevenly, by eCR, lab reporting, IZ Gateway, and syndromic surveillance. The real opportunity sits in one question about AI: a network that can handle the next emergency without another interface project. Court cases Particle v. Epic: The Naughty Schoolteacher (Sep 4): After a summer-long vigil, the answer on Epic’s early summary judgment bid is two paragraphs and a remedial assignment. Particle advances to the next grade, and market definition gets another year of discovery. The Epic Discovery Files (Sep 8): Texas’s motions to compel arrive with a 251-page appendix of requests, objections, and meet-and-confer letters with Cravath. Inside: Epic using generative AI for document review, denied interoperability requests in scope, and Noerr-Pennington raised against lobbying discovery. Epic v. Health Gorilla: “Working as Designed” (Sep 9): Epic wants nothing to do with the data breach MDL, and explaining why puts fresh discovery on the public docket. The spiciest allegation: Health Gorilla told GuardDog to scrub its law firm business from its website instead of cutting off access. Veeva v. Epic: Legal Bypass Surgery (Sep 15): Veeva asks the Wisconsin Supreme Court to skip the Court of Appeals, while law professors and three policy groups line up as amici. Meanwhile, Epic’s lawyers apologize for another round of citation errors, including a quote that never existed. Texas v. Epic: Behind the Black Bars (Sep 17): The court portal served up Epic’s unredacted filings, revealing a $5 million document review budget and the AI workflow behind it. Also inside: the 200-plus company names Texas wants searched, and one very expensive Zoom invitation. OpenEvidence v. Doximity: Consequences Will Follow (Sep 25): OpenEvidence tells the court it will not comply with a discovery order, and its own lawyers at Quinn Emanuel say they won’t defend the choice. Add years of Slack reported unrecoverable, and Rule 37 sanctions come into view. Health Tech Keeps Choosing Violence (Sep 28): Doximity moves to end OpenEvidence’s case, Epic asks Texas to show its work, and a sleepy Audacious Inquiry patent fight sprouts antitrust and information blocking counterclaims. The main event is a long-sealed Cognizant v. Infosys ruling that hints where system of record antitrust claims can survive. EHRs One Verb for Oracle Health (Sep 14): Oracle’s earnings call quantifies every data center to the decimal point, while Oracle Health gets a single verb: “accelerate.” Panning the few healthcare mentions turns up an agentic care management system, a research-to-care ledger play, and the question of whether healthcare gets Larry’s patience. Epic’s Forretress Under Siege (Sep 30): Judy Faulkner tells a panel Epic paused hundreds of projects to harden its software and calls it a “shame,” while a spokesperson insists the roadmap hasn’t changed. Project Glasswing, a Pokémon-branded QAN sprint, and a trove of Jodel grievances reconcile the two Epics and preview the Jevons paradox coming for all software. Industry Analysis Scanning for a Network (Sep 1): Scan.com raises $220M to build the imaging network labs never got, speedrunning Zocdoc’s consumer-to-B2B pivot. Its wedge to network density may be the most American one available: personal injury litigation. The Front Desk Wants the Damn Whole Building (Sep 16): Hello Patient buys Converse Health, pushing its AI front desk into referrals, chart work, and prior auth. The copilot categories keep blurring, and your distribution partner is still your final boss. Cross-industry Comparisons A Different Patchwork Quilt (Sep 10): Healthcare loves to envy open banking, but the US version has no mandate, a toll booth at Chase, and data quality problems of its own. The grass isn’t greener; it’s another American patchwork quilt, and perhaps a worse one. Hail, Benihydra (Sep 21): Salesforce brings its platform into Claude, Slack, and its own agent, inviting the interfaces that might replace it. Cut off one head and more grow back, so long as the records underneath stay put. Living on A Trade Secret Prayer (Sep 22): Six credit unions are suing Fiserv, the Epic of core banking, by claiming their own member records as trade secrets. Banking has no Cures Act, so its lawyers reach for legal alchemy that healthcare has already tried. Other News None this month External Media Nabla Accelerate NYC: I kicked off fall conference season at Nabla’s Accelerate event in New York, where Delphine Groll opened by asking the room to picture the company it wants to become and the one it doesn’t. I liked her framework of bureaucracy, fear, and ego as the blockers. I also love vendor conferences/events in general - different vibe than industry biggies. Healthcare 101 with Nikhil Krishnan: I briefly guest lectured Out-Of-Pocket’s Healthcare 101 class. Appreciated Nikhil’s takeaways cover whether AI doctors can query HIEs, why healthcare’s data-liberation rules beat most industries’, and the hi-res graphic is in the comments. HCN: Epic Probed by the FTC: I joined the HCN guys to talk through the FTC’s investigation into Epic. Cedric’s new hairdo was an unexpected plot twist. The episode also covers MFN drug pricing, healthcare M&A and Eli Lilly’s acquisition streak. Fall Conferences: At eHealth Exchange’s Annual Meeting in Austin on Oct 27, I’ll moderate a panel on the tensions between AI, HIEs, and timely patient access with Jean Ross (Primary Record), Therasa Bell (Kno2), Byron Crowe (Doctronic), and Michael Marchant (Freenome). Here’s the rest of my schedule if you want to meet up: CommonWell (Redwood Shores, CA): Oct 13-14 Will be participating in a fun Jeopardy event Open@Epic (Madison, WI): Oct 20-23 Will be enjoying Verona, Willy Street, and other local adventures eHealth Exchange and Sequoia Project (Austin, TX): Oct 27-29 Yeehaw HLTH (Vegas): Nov 15-18 Groundhog Day, Venetian Edition RSNA (Chicago): Nov 30-Dec 2 See me at “Governing AI in Breast Imaging: What Health Systems Are Actually Doing” Digital Health Counsel 2026 AI Summit (Seattle): December 2-3 Will likely be speaking to a bunch of lawyers about information blocking Posts I Liked ChatGPT’s Epic integration: game changer or nothing burger?: Joshua Liu, MD offers five thoughts on OpenAI’s Epic launch, starting from the point that it rides the same open APIs available to anyone. He argues read-only access leaves ordering to Art and the ambient startups, and asks why HCA is piloting it alongside Commure. He’s sorta a must-follow at this point - consistently excellent, thought-provoking takes. Epic, Lilly, and the Discovery pass: Seth Chaney reads Epic’s first major Discovery deal (with Eli Lilly), as well as its revised developer terms on commercial displays, as the pipe finally opening between EHRs and pharma. Life sciences and health continue to collide. Scott Rossignol on EHR payer platforms and ePA fees: Scott argues the top ambulatory EHR vendors are turning the prior auth mandate into a per-member-per-year toll on payers, for an API whose operating cost has nothing to do with covered lives. His fix is two lines of regulatory text: put the CRD/DTR/PAS certification criteria in the Base EHR definition, and bring payer-facing ePA connectivity under § 170.404’s cost-based fee rules. It’s a good solution. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
AAPS PharmSci 360 Offers Fresh Insights for Industry Scientists
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
National Forum To Convene on Cutting Edge Science that Drives Solutions In Harmony with Nature - Beyond Pesticides Daily News Blog
The 43rd National Forum Series, Advancing Science on Pesticides, Taking Action in Harmony with Nature, and Sustaining Life —scheduled to begin on October 21, 2026, 1:00-3:30pm (Eastern time, US)—will focus on cutting edge science that both (1) defines the limitations of health and environmental protection standards governing allowed toxic pesticide use and (2) informs the urgent need to advance alternatives not reliant on hazardous inputs. The Forum is free to all participants. ➡️ Register HERE.
Menstrual tracking apps lack evidence of health and performance benefits
Digital menstrual tracking risks creating more harm than benefit and requires greater scrutiny, warn experts in The BMJ today.
Minaris Adds Dedicated Viral Vector Business Unit
Minaris is adding a dedicated viral vectors business unit, redefining its business model around that, cell therapies, and advanced testing.